WorldStage Newsonline– Neimeth International Pharmaceuticals Plc which is into manufacturing and marketing of pharmaceuticals and animal health products has released its statement of profit or loss and other comprehensive income for the year ended 30 September 2020 with an increase in turnover to N2.839 billion compared with  N2.371 billion in 2019. However, profit for the year from continued operation dropped by 3.48% to N212.476 million compared with N220.147 million in 2019. Neimeth International Pharmaceuticals Plc, quoted on the Nigerian Stock Exchange was incorporated on 30 August 1957 as a limited liability company and commenced operation in January 1958. On 14 May 1997, Pfizer Inc. NY divested from the Company through a management buyout.